119 HR 8763 IH: Treatment and Relief through Emerging and Accessible Therapy for PTSD VA Act U.S. House of Representatives 2026-05-12 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I119th CONGRESS2d SessionH. R. 8763IN THE HOUSE OF REPRESENTATIVESMay 12, 2026Mr. Perry introduced the following bill; which was referred to the Committee on Veterans' AffairsA BILLTo direct the Secretary of Veterans Affairs to furnish stellate ganglion block to veterans with post-traumatic stress disorder, and for other purposes.

1.

Short title

This Act may be cited as the Treatment and Relief through Emerging and Accessible Therapy for PTSD VA Act or the TREAT PTSD VA Act.

2.

Provision of stellate ganglion block to veterans with post-traumatic stress disorder

(a)

Provision to veterans

(1)

In general

Subchapter II of chapter 17 of title 38, United States Code, is amended by adding at the end the following new section:

1720M.

Provision of stellate ganglion block for certain veterans

(a)

In general

The Secretary shall furnish stellate ganglion block to any veteran who— (1)is enrolled in the patient enrollment system under section 1705 of this title; (2)has been diagnosed with post-traumatic stress disorder; and (3)has elected to receive stellate ganglion block after being informed by a qualified health care provider of the risks and benefits of stellate ganglion block. (b)

Provision of care

The Secretary may furnish stellate ganglion block under subsection (a) through a medical facility of the Department or through a health care provider specified in section 1703(c) of this title.

. (2)

Clerical amendment

The table of contents at the beginning of chapter 17 of title 38, United States Code, is amended by inserting after the item relating to section 1720L the following new item: 1720M. Provision of stellate ganglion block for certain veterans.. (b)

Update of joint clinical practice guideline

(1)

Update of guideline

Not later than 180 days after the date of the enactment of this Act, the Secretary of Veterans Affairs shall update the guideline titled the VA/DOD Clinical Practice Guideline (CPG) for the Management of PTSD (or such successor guideline) to ensure the guideline— (A)reflects the availability of stellate ganglion block as a therapy option; and (B)includes information on the clinical indicators and contraindicators for such therapy option. (2)

Notification

Upon updating the guideline under paragraph (1), the Secretary shall notify the Committees on Veterans’ Affairs of the House of Representatives and the Senate of such update. (c)

Effective date

The amendment made by subsection (a) shall take effect on the date that is 180 days after the date of the enactment of this Act.